Engage Therapeutics
Engage Therapeutics is a biopharmaceutical company bringing innovative medicines to market. The Company’s lead investigational drug is Staccato® alprazolam, a small, easy-to-use hand-held drug-device combination product that leverages an FDA-approved delivery system with FDA-approved alprazolam for the cessation of active and acute epileptic seizures. Staccato alprazolam in a Phase 2a proof of concept study demonstrated reduction of seizure in a photosensitivity model. The product will proceed into an advanced clinical setting leveraging a 505(b)(2) regulatory pathway.
Domain
engagetherapeutics.com
Country
United StatesIndustry
BiopharmaEmployees
1-10
Last Funding
$23.6M
Founded
2016
Tech Stack (10 technologies)
Frequently Asked Questions
What technologies does Engage Therapeutics use?+
Engage Therapeutics uses 10 technologies including Google Tag Manager, OneTrust, ReadSpeaker.
What industry is Engage Therapeutics in?+
Engage Therapeutics operates in the Biopharma industry.
Where is Engage Therapeutics based?+
Engage Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026